Chronic Obstructive Pulmonary Disease Endpoints Study

NCT00358358 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Fluticasone Propionate/Salmeterol 500/50mcg combination
DRUG: Fluticasone Propionate 500mcg
DRUG: Salmeterol 50mcg

Sponsor

GlaxoSmithKline